Clinical criteria cannot identify all patients who develop acute respiratory distress syndrome, which might indicate the need to develop new tools that improve reliability and diagnostic accuracy. Nevertheless, being conscious of the limitations of the American-European consensus conference criteria continues to be useful in clinical daily practice because these patients would benefit from treatments. This and other management strategies have been evaluated in patients who, fulfilling the clinical criteria of acute respiratory distress syndrome, could not have diffuse alveolar damage.